Professor Carole Longson
Senior Advisor
Carole has a 30-year executive and international board career in life sciences and is a respected international leader in Health Technology Assessment and Market Access.
After a career in drug discovery at GSK, she pioneered NICE’s Technology Appraisal and Health Tech evaluation programmes as an Executive Director at NICE for 18 years from 2000-2018 and was Chief Scientific Officer at the Association of the British Pharmaceutical Industry from 2018-2020. She is a former President of Health Technology Assessment International, was a member of the Executive Committee of the European Network in Health Technology Assessment (EUnetHTA), and has been a member of Scientific Advisory Committees at the European Commission and the WHO.
She is currently Vice Chair of the Medicines Discovery Catapult UK and senior counsel in HTA and market access for the public, private and investment sectors. Throughout her career, she has championed the public and private sectors collaborating to ensure medical innovation benefits patients in a way that is sustainable for healthcare systems.